Skorzewiak / Shutterstock.com
1 October 2024NewsEuropeLiz Hockley

UK judge ends J&J unit’s hopes of reviving Stelara patent

Janssen Biotech denied permission to appeal invalidation of ustekinumab patent | Samsung Bioepis convinced UK court to revoke patent in July.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
14 June 2023   Deal thought to be aimed at helping pharma giant attain sales target as patents start to expire | Israeli drugmaker will join with Icelandic firm to unveil a copycat version of blockbuster treatment by 2025.
Big Pharma
25 May 2023   Amgen can market biosimilar version of Stelara from January 2025 | J&J had alleged infringement of two Stelara patents.